We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ablate and pace for patients with atrial fibrillation: a fragile option?
- Authors
Kaur, Hargun; McIntyre, William F; Belley-Côté, Emilie P
- Abstract
This commentary refers to 'AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial', by M. Brignole I et al i . https://doi.org/10.1093/eurheartj/ehab569 and the discussion piece "Is APAF-CRT robust enough to change clinical practice?" In the Ablate and Pace for Atrial Fibrillation - cardiac resynchronization therapy (APAF-CRT) trial, Brignole I et al i . compared pharmacological rate control (drug) with ablation and biventricular pacing (ablation + CRT) in patients with severely symptomatic AF lasting >6 months, narrow QRS, and at least one prior heart failure hospitalization. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
- Subjects
ATRIAL fibrillation; CARDIAC pacing
- Publication
European Heart Journal, 2022, Vol 43, Issue 22, p2160
- ISSN
0195-668X
- Publication type
Article
- DOI
10.1093/eurheartj/ehac091